In the TNBS colitis model, PGE2 has been shown to exacerbate colonic inflammatory processes and colitis severity through activation of the IL-23/IL17 axis and by increasing local Th17 cell numbers [18, 25, 30, 31]. The gene discussed is IL17A; the disease is colitis.